malondialdehyde has been researched along with Coronary Restenosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Hui, F; Li, Y; Liu, X; Meng, R; Si, J; Yang, B | 1 |
| Hu, A; Hu, P; Huang, B; Huang, J; Jiang, Q; Li, L; Li, Y; Shi, W; Wu, Q; Xu, S | 1 |
| Amrein, K; Binder, J; Cvirn, G; Ferstl, U; Froehlich, H; Hallström, S; Hörl, G; Jürgens, G; Koidl, C; Ledinski, G; Scharnagl, H; Stojakovic, T; Tafeit, E; Trauner, M | 1 |
| Curtiss, LK; Han, KR; Lau, HK; Miller, ER; Segev, A; Shortal, B; Strauss, BH; Tsimikas, S; Witztum, JL | 1 |
| Chang, WC; Chen, CW; Chen, HC; Hung, JS; Shu, MJ; Wu, CH | 1 |
| Hara, M; Saikawa, T; Shigematsu, S; Takahashi, N; Yoshimatsu, H | 1 |
1 trial(s) available for malondialdehyde and Coronary Restenosis
| Article | Year |
|---|---|
Increased incidence of coronary in-stent restenosis in type 2 diabetic patients is related to elevated serum malondialdehyde-modified low-density lipoprotein.
Topics: Aged; Biomarkers; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus, Type 2; Female; Humans; Incidence; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Risk Factors; Stents; Tunica Intima | 2007 |
5 other study(ies) available for malondialdehyde and Coronary Restenosis
| Article | Year |
|---|---|
Linagliptin protects rat carotid artery from balloon injury and activates the NRF2 antioxidant pathway.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Animals; Carotid Arteries; Carotid Artery Injuries; Coronary Restenosis; Cytokines; Dipeptidyl-Peptidase IV Inhibitors; Glutathione Peroxidase; Inflammation Mediators; Linagliptin; Male; Malondialdehyde; Neointima; NF-E2-Related Factor 2; Oxidative Stress; Rats, Wistar; Superoxide Dismutase; Up-Regulation | 2019 |
Naringenin attenuates carotid restenosis in rats after balloon injury through its anti-inflammation and anti-oxidative effects via the RIP1-RIP3-MLKL signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antioxidants; Carotid Arteries; Coronary Restenosis; Flavanones; Gene Expression Regulation; Glutathione; Hyperplasia; Inflammation; Interleukin-1beta; Male; Malondialdehyde; Oxidative Stress; Proliferating Cell Nuclear Antigen; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinases; Receptors, Cell Surface; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.
Topics: Adult; Aged; Aged, 80 and over; Antigen-Antibody Complex; Apolipoproteins B; Cholesterol, LDL; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Male; Malondialdehyde; Middle Aged; Peripheral Arterial Disease; Simvastatin | 2016 |
Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Apolipoprotein B-100; Apolipoproteins B; Autoantibodies; Autoantigens; Catheterization; Cohort Studies; Coronary Restenosis; Epitopes; Humans; Immunoglobulin G; Immunoglobulin M; Lipoprotein(a); Lipoproteins, LDL; Malondialdehyde; Oxidation-Reduction; Phospholipids; Prospective Studies; Stents | 2004 |
Elucidating the inhibitory mechanisms of magnolol on rat smooth muscle cell proliferation.
Topics: Angioplasty, Balloon, Coronary; Animals; Antioxidants; Biphenyl Compounds; Blotting, Western; Caspase 3; Caspases; Cell Cycle; Cell Proliferation; Cells, Cultured; Coronary Restenosis; DNA; Dose-Response Relationship, Drug; Lignans; Malondialdehyde; Muscle, Smooth, Vascular; NF-kappa B; Proliferating Cell Nuclear Antigen; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Rats; Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2005 |